A new step towards targeting tau
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical)
Reference10 articles.
1. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches;Boxer;Lancet Neurol,2017
2. Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial;Boxer;Lancet Neurol,2019
3. A randomized, single ascending dose study of intravenous BIIB092 in healthy participants;Qureshi;Alzheimers Dement,2018
4. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study;Bensimon;Brain,2009
5. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial;Boxer;Lancet Neurol,2014
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties;Molecular Psychiatry;2020-01-15
2. The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers;Frontiers in Aging Neuroscience;2019-12-04
3. BrightFocus Alzheimer’s Fast Track 2019;Molecular Neurodegeneration;2019-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3